We are live on
!
Find out more
WI
Wedgewood Investors Portfolio holdings
AUM
$97.4M
1-Year Est. Return
31.05%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+31.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.6M
AUM Growth
+$7.35M
(+8.7%)
Cap. Flow
-$2.34M
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
41.41%
Holding
102
New
6
Increased
17
Reduced
25
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$203K |
| 2 |
Clorox
CLX
|
+$196K |
| 3 |
Schwab US Broad Market ETF
SCHB
|
+$194K |
| 4 |
Paychex
PAYX
|
+$191K |
| 5 |
American Express
AXP
|
+$189K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Erie Indemnity
ERIE
|
+$2.23M |
| 2 |
Intel
INTC
|
+$530K |
| 3 |
Shell
SHEL
|
+$217K |
| 4 |
Equifax
EFX
|
+$212K |
| 5 |
Apple
AAPL
|
+$67K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.02% |
| 2 | Industrials | 17.65% |
| 3 | Technology | 14.86% |
| 4 | Consumer Staples | 9.65% |
| 5 | Healthcare | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vertex Pharmaceuticals
VRTX
$133B
| $465K | 0.51% |
1,000
| – | – |
|
52
Phillips 66
PSX
$86B
| $447K | 0.49% |
3,400
| – | – |
|
53
Adobe
ADBE
$109B
| $446K | 0.49% |
862
| – | – |
|
54
Corning
GLW
$136B
| $446K | 0.49% |
9,872
| – | – |
|
55
AbbVie
ABBV
$438B
| $441K | 0.48% |
2,232
| – | – |
|
56
Invesco QQQ Trust
QQQ
$479B
| $439K | 0.48% |
900
| – | – |
|
57
Verizon
VZ
$195B
| $437K | 0.48% |
9,726
-230
| -2% | -$9.6K |
|
58
Thermo Fisher Scientific
TMO
$222B
| $433K | 0.47% |
700
| – | – |
|
59
MetLife
MET
$61.7B
| $432K | 0.47% |
5,233
| – | – |
|
60
Becton Dickinson
BDX
$48.9B
| $405K | 0.44% |
1,681
-150
| -8% | -$35.2K |
|
61
3M
MMM
$93.9B
| $390K | 0.43% |
2,853
| – | – |
|
62
Caterpillar
CAT
$385B
| $365K | 0.4% |
933
| – | – |
|
63
Pfizer
PFE
$154B
| $364K | 0.4% |
12,573
+892
| +8% | +$26K |
|
64
AT&T
T
$165B
| $355K | 0.39% |
16,149
+67
| +0.4% | +$1.33K |
|
65
Lowe's Companies
LOW
$123B
| $355K | 0.39% |
1,309
| – | – |
|
|
DFS
66
DELISTED
Discover Financial Services
DFS
| $354K | 0.39% |
2,520
| – | – |
|
67
iShares Russell Mid-Cap ETF
IWR
$57.5B
| $353K | 0.39% |
4,005
-309
| -7% | -$26K |
|
68
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
| $339K | 0.37% |
1,287
| – | – |
|
69
US Bancorp
USB
$100B
| $333K | 0.36% |
7,278
+13
| +0.2% | +$570 |
|
70
Qualcomm
QCOM
$170B
| $333K | 0.36% |
1,956
-20
| -1% | -$3.53K |
|
71
UnitedHealth
UNH
$371B
| $328K | 0.36% |
561
-30
| -5% | -$17K |
|
72
FedEx
FDX
$76.9B
| $316K | 0.34% |
1,154
| – | – |
|
73
PNC Financial Services
PNC
$100B
| $314K | 0.34% |
1,697
| – | – |
|
74
Bristol-Myers Squibb
BMY
$132B
| $311K | 0.34% |
6,015
+483
| +9% | +$22.7K |
|
75
Southern Company
SO
$105B
| $311K | 0.34% |
3,450
| – | – |
|
Similar funds
CSW
JKSF
BFA
BJB
ACM
YF
WM
SFO
Wedgewood Investors's Q3 2024 Portfolio in Review
As of Q3 2024, Wedgewood Investors held 102 positions worth $91.6M, up 8.7% from $84.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Wedgewood Investors's Q3 2024 filing shows 6 new, 17 increased, 25 reduced and 2 closed positions. Its largest new stake was Sherwin-Williams: 583 shares worth $223K. The largest sale was Erie Indemnity, an estimated $2.23M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.
- Wedgewood Investors's largest Q3 2024 buy was Sherwin-Williams: 583 shares worth $223K.
- Wedgewood Investors added most to ExxonMobil in Q3 2024, an estimated $59.4K increase.
- Wedgewood Investors's biggest Q3 2024 reduction was Erie Indemnity, cutting an estimated $2.23M.
- Wedgewood Investors fully exited Intel in Q3 2024, selling an estimated $530K.
- Wedgewood Investors's ten largest holdings make up 41% of its $91.6M portfolio in Q3 2024.
- Wedgewood Investors opened 6 new positions and closed 2 in Q3 2024.
- Wedgewood Investors's portfolio value rose 8.7% quarter-over-quarter to $91.6M.
Based on Wedgewood Investors's 13F filing for Q3 2024, filed 31 Oct 2024.